Australia markets closed

Lisata Therapeutics Inc (8NE.DU)

Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
3.12000.0000 (0.00%)
At close: 07:32PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
12,796
12,734
43,460
17,576
9,253
-
Selling general and administrative
12,669
12,974
14,141
11,474
9,892
-
Total operating expenses
25,465
25,708
57,601
29,050
19,145
-
Operating income or loss
-25,465
-25,708
-57,601
-29,050
-19,145
-
Interest expense
0
-
-
-
-
0
Total other income/expenses net
2,283
2,538
897
76
132
-
Income before tax
-23,182
-23,170
-56,704
-28,974
-19,013
-
Income tax expense
-3,128
-2,330
-2,479
-1,508
-10,872
-
Income from continuing operations
-20,054
-20,840
-54,225
-27,466
-8,141
-
Net income
-20,054
-20,840
-54,225
-27,466
-8,150
-
Net income available to common shareholders
-20,054
-20,840
-54,225
-27,466
-8,150
-
Basic EPS
-1.11
-2.58
-10.47
-7.45
-7.95
-
Diluted EPS
-1.11
-2.58
-10.47
-7.45
-7.95
-
Basic average shares
8,011
8,073
5,180
3,688
1,029
-
Diluted average shares
8,011
8,073
5,180
3,688
1,029
-